Medicament Injection Device

Sanofi

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application 29/483,790, filed Mar 3, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Patent	Title	Holder	Status	Expires	Time remaining	Confidence
US D739,932	Medicament Injection Device Sanofi and Regeneron Pharmaceuticals, Inc. In force Term ends Sep 29, 2029 · High confidence	Sanofi and Regeneron Pharmaceuticals, Inc.	In force	Term ends Sep 29, 2029	Term ends Sep 29, 2029	High confidence
US D748,253	Cap for a Medicament Injection Device Sanofi and Regeneron Pharmaceuticals, Inc. In force Term ends Jan 26, 2031 · High confidence	Sanofi and Regeneron Pharmaceuticals, Inc.	In force	Term ends Jan 26, 2031	Term ends Jan 26, 2031	High confidence
US D782,033	Medicament Injection Device Sanofi and Regeneron Pharmaceuticals, Inc. In force Term ends Mar 21, 2031 · High confidence	Sanofi and Regeneron Pharmaceuticals, Inc.	In force	Term ends Mar 21, 2031	Term ends Mar 21, 2031	High confidence
US D753,291	Medicament Injection Device Sanofi and Regeneron Pharmaceuticals, Inc. In force Term ends Apr 5, 2031 · High confidence	Sanofi and Regeneron Pharmaceuticals, Inc.	In force	Term ends Apr 5, 2031	Term ends Apr 5, 2031	High confidence
US D787,046	Medicament Injection Device Sanofi and Regeneron Pharmaceuticals, Inc. In force Term ends May 16, 2032 · High confidence	Sanofi and Regeneron Pharmaceuticals, Inc.	In force	Term ends May 16, 2032	Term ends May 16, 2032	High confidence
US D789,519	Medicament Injection Device Sanofi and Regeneron Pharmaceuticals, Inc. In force Term ends Jun 13, 2032 · High confidence	Sanofi and Regeneron Pharmaceuticals, Inc.	In force	Term ends Jun 13, 2032	Term ends Jun 13, 2032	High confidence
US D802,751	Medicament Injection Device Sanofi and Regeneron Pharmaceuticals, Inc. In force Term ends Nov 14, 2032 · High confidence	Sanofi and Regeneron Pharmaceuticals, Inc.	In force	Term ends Nov 14, 2032	Term ends Nov 14, 2032	High confidence
US D812,740	Medicament Injection Device Sanofi and Regeneron Pharmaceuticals, Inc. In force Term ends Mar 13, 2033 · High confidence	Sanofi and Regeneron Pharmaceuticals, Inc.	In force	Term ends Mar 13, 2033	Term ends Mar 13, 2033	High confidence

8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.